Logo
x

Search

Subscribe Now

Abbvie

The CHMP Adopts Positive Opinion for AbbVie’s Rinvoq (Upadacitinib) to Treat Giant Cell Arteritis in Adults

The CHMP Adopts Positive Opinion for AbbVie’s Rinvoq (Upadacitinib) to Treat Giant Cell Arteritis in Adults

  • February 28, 2025
AbbVie Collaborates with Xilio Therapeutics to Develop Next-Generation Tumor-Activated Immunotherapies

AbbVie Collaborates with Xilio Therapeutics to Develop Next-Generation Tumor-Activated Immunotherapies

  • February 13, 2025
Abbvie Reports the US FDA Approval for Emblaveo to Treat Complicated Intra-Abdominal Infections (cIAI)

Abbvie Reports the US FDA Approval for Emblaveo to Treat Complicated Intra-Abdominal Infections (cIAI)

  • February 10, 2025
Abbvie Partners with Neomorph to Develop Novel Molecular Glue Degraders for Oncology and Immunology

Abbvie Partners with Neomorph to Develop Novel Molecular Glue Degraders for Oncology and Immunology

  • January 27, 2025
AbbVie and Simcere Zaiming Collaborate to Develop SIM0500 for Treating Multiple Myeloma

AbbVie and Simcere Zaiming Collaborate to Develop SIM0500 for Treating Multiple Myeloma

  • January 15, 2025
AbbVie to Bolster its Immunology Pipeline Through the Acquisition of Nimble Therapeutics

AbbVie to Bolster its Immunology Pipeline Through the Acquisition of Nimble Therapeutics

  • December 16, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.